Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/17/2025

Chemosis Complications Management

Initial Assessment and Classification

  • The American Academy of Ophthalmology recommends determining the underlying etiology and severity of chemosis complications, including infectious vs. inflammatory causes, which require different management approaches, and assessing for corneal epithelial defects using fluorescein staining with cobalt blue light 2
  • The British Journal of Dermatology guidelines suggest that chemosis severity grading should assess for conjunctival hyperemia, pseudomembrane formation, or ocular surface epithelial defects, and identify associated complications such as lagophthalmos, corneal exposure, symblepharon formation, or conjunctival fornix foreshortening 3

First-Line Pharmacologic Management

  • The American College of Physicians recommends initiating topical corticosteroids immediately for marked chemosis, lid swelling, or epithelial sloughing, with a strength of evidence of high 1
  • The American Academy of Ophthalmology suggests using preservative-free formulations, such as dexamethasone 0.1%, when corneal epithelial defects are present to avoid additional surface damage, with a strength of evidence of moderate 2
  • The American College of Physicians recommends monitoring closely for complications, including increased intraocular pressure and cataract formation, with prolonged use of topical corticosteroids, with a strength of evidence of high 1

Adjunctive Topical Therapy

  • The British Journal of Dermatology guidelines recommend applying preservative-free artificial tears, such as hyaluronate or carmellose, every 2 hours throughout the acute phase, with a strength of evidence of low 3, 2
  • The American Academy of Ophthalmology suggests adding broad-spectrum topical antibiotics, such as moxifloxacin or levofloxacin, four times daily, when corneal epithelial defects are present to prevent secondary infection, with a strength of evidence of moderate 2

Daily Ophthalmologic Care

  • The British Journal of Dermatology guidelines recommend mandatory daily ophthalmologic review during the acute illness to monitor progression and complications, with a strength of evidence of high 3, 2
  • The American Academy of Ophthalmology suggests daily removal of inflammatory debris and lysis of conjunctival adhesions by an ophthalmologist or trained nurse using saline irrigation, squint hook, and forceps, with a strength of evidence of moderate 2

Mechanical and Supportive Measures

  • The American College of Physicians recommends using cold compresses to provide symptomatic relief by reducing edema and inflammation, with a strength of evidence of low 1
  • The American Academy of Ophthalmology suggests establishing a moisture chamber with polyethylene film if significant chemosis or lid involvement prevents complete closure, preventing corneal exposure and ulceration, with a strength of evidence of moderate 2

Critical Pitfalls to Avoid

  • The American Academy of Ophthalmology recommends avoiding the use of preserved artificial tears with severe epithelial defects, as these worsen surface damage, with a strength of evidence of high 2
  • The British Journal of Dermatology guidelines suggest avoiding delay in ophthalmologic consultation, as daily review is mandatory during the acute phase, with a strength of evidence of high 3
  • The American College of Physicians recommends avoiding the use of topical steroids without close monitoring for infection, especially when corneal epithelial defects exist, with a strength of evidence of high 1, 2

REFERENCES

1

Treatment of Alkaline Eye Burns [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment Options for Chemosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025